Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
12 angezeigte Treffer · Seite 2, keine Gesamtzahl für „UGT1A9“
Suchtreffer
Begriffe & Kennungen
Sorafenib Accord · 4.5 · UGT1A1 and UGT1A9 substrates
Eintrag öffnenSteglatro · 4.5 · Effects of other medicinal products on the pharmacokinetics of ertugliflozin Metabolism by UGT1A9 and UGT2B7 i
Eintrag öffnenSteglujan · 4.5 · Effects of other medicinal products on the pharmacokinetics of ertugliflozin Metabolism by UGT1A9 and UGT2B7 i
Eintrag öffnenStivarga · 4.5 · 7 Co-administration of a strong UGT1A9 inhibitor (e.g. mefenamic acid, diflunisal, and niflumic acid) during r
Eintrag öffnenStivarga · 4.5 · Inhibitors of CYP3A4 and UGT1A9/inducers of CYP3A4 In vitro data indicate that regorafenib is metabolized by c
Eintrag öffnenStivarga · 4.5 · UGT1A1 and UGT1A9 substrates In vitro data indicate that regorafenib as well as its active metabolite M-2 inhi
Eintrag öffnenTavlesse · 4.5 · 8 CYP3A4 and UGT1A9 are involved in the metabolism of R406. R406 is a substrate of P-gp but not of other major
Eintrag öffnenUDP-Glucuronosyltransferase 1A9
Eintrag öffnenVerquvo · 4.5 · UGT1A9/1A1 inhibitors Vericiguat is metabolised by UGT1A9 and UGT1A1. Inhibitors of these UGTs may result in i
Eintrag öffnenVerquvo · 4.5 · Vericiguat is eliminated via multiple routes in humans. The dominant route is glucuronidation via UGT1A9 and U
Eintrag öffnenXigduo · 4.5 · Following coadministration of dapagliflozin with mefenamic acid (an inhibitor of UGT1A9), a 55% increase in da
Eintrag öffnenZtalmy · 4.5 · Ganaxolone is a substrate for UGT1A3, UGT1A6, UGT1A9, and UGT2B15. No formal drug-drug interaction studies hav
Eintrag öffnen